Calling All Wound Care Warriors

June is Wound Healing Awareness Month. We are proud to launch our Wound Healing Awareness Month campaign to raise awareness, featuring the health care professionals who treat chronic and complex wounds and highlighting the use of Cryopreserved Umbilical Cord Allograft as an adjunct therapy to help promote wound healing.

Wound Of The Month

As a pioneer in human birth tissue technology for managing chronic and non-healing wounds, Amniox would like to bring your attention to the current wound epidemic.

According to Medicare, nearly 8.2 million patients suffer from chronic or non-healing wounds such as diabetic foot ulcers (DFUs) and pressure ulcers, ranging in Medicare costs between $28.1 billion to $96.8 billion, with surgical wounds being the highest followed by DFUs1

Necrotizing fasciitis is an uncommon but severe infection often involving the foot and ankle, especially in diabetic patients. These infections carry a very high morbidity and mortality rate, frequently resulting in amputation. These can be very difficult wounds to resolve after the initial debridement and require aggressive wound care for limb salvage.

The patient on the image to the right is a 64-year-old diabetic with PAD, Neuropathy, HTN, CAD with prior MI. Dr. Thomas Fusco applied NEOX® CORD 1K as an adjunct therapy in promoting healing of a complex wound resulting from Necrotizing Fasciitis.

Read the full case study here.

The Amniox Advantage

Wound Healing Awareness Month reminds us that saving lives begins with healing complex chronic wounds. Chronic wounds plague 9-12 million Americans each year2. More than 50% become infected3, of which 20% are amputated4. The mortality rate for leg ulcers after the first amputation is 50% in the first three years and 70% after five years.2

Amniox has 35 years of clinical research & development harnessing the power of human birth tissue. Our proprietary CryoTek™ processing method preserves the naturally occurring complex HC-HA/PTX3 in our platform technology that promotes healing. NEOX wound allograft is a powerful adjunct therapy designed specifically for chronic and non-healing Wagner Grade 3-4 DFUs.

If you are interested in learning first-hand about our advanced wound-care products, sign up for our Physician Portal where you will find valuable educational resources, case studies, and webinars.

Benefits of NEOX CORD 1K

Understand the benefits of NEOX CORD 1K in chronic wound care management – use the flow chart above to help identify when to use NEOX CORD 1K, a cryopreserved umbilical cord and amniotic membrane wound allograft.

The NEOX family of products is used to manage chronic and complex wounds. The NEOX wound allograft is a powerful adjunct therapy particularly appropriate for chronic and non-healing wounds, such as Wagner Grade 3-4 DFUs, supporting better wound healing with a complete closure rate of 79% on average of 16 +/- 9.25 weeks, range 4 to 44 with a median of one application.1

Click here to view clinical evidence.

Second Chances Begin with NEOX

Saving lives begins with healing complex chronic wounds. Chronic wounds plague 9-12 million Americans each year1, more than 50% become infected2, and 20% result in amputation3. The mortality rate for leg ulcers after the first amputation is 50% in the first three years and 70% after five years1.

NEOX® CORD 1K allograft is a cryopreserved umbilical cord backed by scientific evidence to treat non-healing wounds such as Wagner grade 3-4 DFUs when used as an adjunct therapy. In a clinical study, patients treated with NEOX CORD 1K and standard of care for Wagner 3-4 DFUs, achieved complete epithelialization for an overall healing rate of 87.5%. The average time to wound closure was 13.8 weeks, with an average of 1.68 applications4.

NEOX CORD 1K helps support healing and functional recovery for complex chronic wounds by providing:

  • High closure rates4-6
  • Fewer applications4-6
  • Reduced cost of care4-6

Click here to view clinical study.

Video Testimonials

Dr. Thomas Fusco, DPM

Foot & Ankle Specialist and Podiatric Surgeon with Orthopaedic Associates
Fort Walton Beach, FL.

Harness the power of NEOX® Cryopreserved Umbilical Cord!

Click Here To Learn How

Featured Patient Stories

By Neox Patient

A diabetic patient who contracted COVID and developed clots in his leg and had to have a hemipelvectomy. His wound developed MRSA. The patient was placed on palliative care, but his surgeon did not give up. She debrided the patient’s wound and used NEOX on the wound site. She was unsure NEOX would be enough, especially since this was her first time using it. The patient’s wound has since healed, and he is on his way to a second chance at life. Not all heroes wear capes, but our Wound Care Warriors harness the power of NEOX to help save lives one leg at a time.

By Jim Bishop, Amniox Sales Rep

Jim was working with a doctor who was frustrated with a non-healing complex chronic wound on one of his terminally ill patients. The patient had wounds in both feet that had not healed over one and a half years. Jim asked the doctor for the chance to show him what NEOX could do for that patient. The patient, a 47-year-old male, had lost all ten of his toes to amputation and had other comorbidities, including type 2 diabetes and pancreatic cancer. The doctor was sure he’d need to amputate this patient’s legs if his wounds did not heal. He had already tried other allografts that failed to achieve closure. The doctor placed two NEOX CORD 1K applications on the right foot, which completely healed after two months, and the left foot required three applications. When Jim saw the patient during his final application of NEOX, the patient held a new pair of custom-made orthopedic shoes and was ecstatic to wear shoes again. He thanked Jim profusely and said, “Even if I ‘go’ soon, I am so happy to be able to walk and enjoy my family now!”

Key Webinars

Amniotic Membrane and Umbilical Cord transplantation as an adjunct therapy is experiencing a rapid adoption rate in Limb Salvage treatments. In this webinar, Drs. Thomas Fusco and Jacob Wynes will provide a contemporary overview of human birth tissues, review the underlying biology, present their clinical experience, and share challenging cases specific to a variety of lower extremity applications.

In this webinar, Dr. Javan Bass will present his clinical experience using cryopreserved Umbilical Cord (cUC) allograft to help manage complications and expedite wound healing after lower limb amputation.

Wound Care Chronicles

As Wound Healing Awareness Month (WHAM) continues, we want to share an infographic to raise awareness of the importance of healing chronic wounds as part of our #WoundCareWarriors campaign. This campaign recognizes all wound care professionals as heroes who help save lives one wound at a time. Not all heroes wear capes, but they all have one thing in common – the desire for better patient outcomes.

Our Wound Care Chronicles infographic, which details the alarming facts impacting the quality of life for patients who suffer from DFUs and chronic wounds. See how Amniox Medical is doing its part, providing products made from cryopreserved umbilical cord and amniotic membrane as the weapon of choice for Wound Care Warriors battling complex chronic wounds.

  • Request More Information
    Learn more about how our family of products can orchestrate regenerative healing which may improve patient outcomes. Fill out the form below and a representative will contact you.
  • By clicking the button below, I agree to receive marketing communications from Amniox I am aware that I can unsubscribe at any time.Privacy PolicyDo Not Sell My Personal Information

1. Nussbaum SR, Carter MJ, Fife CE, DaVanzo J, Haught R, Nusgart M, Cartwright D. An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds. Value Health. 2018 Jan;21(1):27-32.
2. ADA. Economics of wound care. 2015.
3. Malhotra, R., Chan C.S., Nather, A., Osteomyelitis in the diabetic foot.
4. Armstrong, Boulton, Bus, NEJM, 2017 4. Raphael A. J Wound Care. 2016 Jul 1;25(Sup7): S10-S17
5. Caputo WJ et al. Wound Repair Regen. 2016 Sept 24(5).